GlaxoSmithKline PLC Director/PDMR Shareholding (7706C)
April 19 2017 - 11:04AM
UK Regulatory
TIDMGSK
RNS Number : 7706C
GlaxoSmithKline PLC
19 April 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Ms E Walmsley
=== ======================== ================================================
b) Position/status Chief Executive Officer
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 13 April 2017 on
Ordinary Shares held in the Company's 2009
Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- --------------------------------
GBP16.47 82.730 (personal contribution)
--------- --------------------------------
GBP16.47 204.873 (personal contribution)
--------- --------------------------------
GBP16.47 223.059 (personal contribution)
--------- --------------------------------
GBP16.47 82.730 (personal contribution)
--------- --------------------------------
GBP16.47 204.858 (personal contribution)
--------- --------------------------------
GBP16.47 223.045 (personal contribution)
--------- --------------------------------
GBP16.47 82.730 (matching shares)
--------- --------------------------------
GBP16.47 204.873 (matching shares)
--------- --------------------------------
GBP16.47 223.059 (matching shares)
--------- --------------------------------
GBP16.47 82.730 (matching shares)
--------- --------------------------------
GBP16.47 204.858 (matching shares)
--------- --------------------------------
GBP16.47 223.045 (matching shares)
--------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
2,042.590
GBP16.47
=== ======================== ================================================
e) Date of the transaction 2017-04-18
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Mr R G Connor
=== ======================== ================================================
b) Position/status President, Global Manufacturing & Supply
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 13 April 2017 on
Ordinary Shares held in the Company's 2009
Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- --------------------------------
GBP16.47 60.585 (personal contribution)
--------- --------------------------------
GBP16.47 139.194 (personal contribution)
--------- --------------------------------
GBP16.47 116.145 (personal contribution)
--------- --------------------------------
GBP16.47 60.585 (personal contribution)
--------- --------------------------------
GBP16.47 116.131 (personal contribution)
--------- --------------------------------
GBP16.47 60.585 (matching shares)
--------- --------------------------------
GBP16.47 139.194 (matching shares)
--------- --------------------------------
GBP16.47 116.145 (matching shares)
--------- --------------------------------
GBP16.47 60.585 (matching shares)
--------- --------------------------------
GBP16.47 116.131 (personal contribution)
--------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
985.280
GBP16.47
=== ======================== ================================================
e) Date of the transaction 2017-04-18
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Mr L Debruyne
=== ======================== ================================================
b) Position/status President, Global Vaccines
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 13 April 2017 on
Ordinary Shares held in the Company's 2009
Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- --------------------------------
GBP16.47 195.213 (personal contribution)
--------- --------------------------------
GBP16.47 195.199 (personal contribution)
--------- --------------------------------
GBP16.47 195.213 (matching shares)
--------- --------------------------------
GBP16.47 195.199 (matching shares)
--------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
780.824
GBP16.47
=== ======================== ================================================
e) Date of the transaction 2017-04-18
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Mr S Dingemans
=== ======================== ================================================
b) Position/status Chief Financial Officer
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 13 April 2017 on
Ordinary Shares held in the Company's 2009
Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- --------------------------------
GBP16.47 115.556 (personal contribution)
--------- --------------------------------
GBP16.47 270.551 (personal contribution)
--------- --------------------------------
GBP16.47 202.642 personal contribution)
--------- --------------------------------
GBP16.47 115.540 (personal contribution)
--------- --------------------------------
GBP16.47 270.537 (personal contribution)
--------- --------------------------------
GBP16.47 202.642 (personal contribution)
--------- --------------------------------
GBP16.47 115.556 (matching shares)
--------- --------------------------------
GBP16.47 270.551 (matching shares)
--------- --------------------------------
GBP16.47 202.642 (matching shares)
--------- --------------------------------
GBP16.47 115.540 (matching shares)
--------- --------------------------------
GBP16.47 270.537 (matching shares)
--------- --------------------------------
GBP16.47 202.642 (matching shares)
--------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
2,354.936
GBP16.47
=== ======================== ================================================
e) Date of the transaction 2017-04-18
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Mr N Hirons
=== ======================== ================================================
b) Position/status SVP, Global Ethics & Compliance
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 13 April 2017 on
Ordinary Shares held in the Company's 2009
Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- --------------------------------
GBP16.47 42.420 (personal contribution)
--------- --------------------------------
GBP16.47 100.034 (personal contribution)
--------- --------------------------------
GBP16.47 73.412 (personal contribution)
--------- --------------------------------
GBP16.47 42.420 (personal contribution)
--------- --------------------------------
GBP16.47 100.034 (personal contribution)
--------- --------------------------------
GBP16.47 73.398 (personal contribution)
--------- --------------------------------
GBP16.47 42.420 (matching shares)
--------- --------------------------------
GBP16.47 100.034 (matching shares)
--------- --------------------------------
GBP16.47 73.412 (matching shares)
--------- --------------------------------
GBP16.47 42.420 (matching shares)
--------- --------------------------------
GBP16.47 100.034 (matching shares)
--------- --------------------------------
GBP16.47 73.398 (matching shares)
--------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
863.436
GBP16.47
=== ======================== ================================================
e) Date of the transaction 2017-04-18
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Mr S A Hussain
=== ======================== ================================================
b) Position/status President, Global Pharmaceuticals
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 13 April 2017 on
Ordinary Shares held in the Company's 2009
Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- --------------------------------
GBP16.47 199.970 (personal contribution)
--------- --------------------------------
GBP16.47 236.389 (personal contribution)
--------- --------------------------------
GBP16.47 202.908 personal contribution)
--------- --------------------------------
GBP16.47 236.389 (personal contribution)
--------- --------------------------------
GBP16.47 202.894 (personal contribution)
--------- --------------------------------
GBP16.47 199.970 (matching shares)
--------- --------------------------------
GBP16.47 236.389 (matching shares)
--------- --------------------------------
GBP16.47 202.908 (matching shares)
--------- --------------------------------
GBP16.47 236.389 (matching shares)
--------- --------------------------------
GBP16.47 202.894 (matching shares)
--------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
2,157.100
GBP16.47
=== ======================== ================================================
e) Date of the transaction 2017-04-18
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =========================================================================
a) Name Mr B McNamara
=== ======================== ===============================================
b) Position/status CEO, GSK Consumer Healthcare
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ===============================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 13 April 2017 on ADSs held
in the Company's 2009 Deferred Annual Bonus
Plan.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- -------------------------------
$41.81 82.979 (personal contribution)
--------- -------------------------------
$41.81 82.979 (matching shares)
--------- -------------------------------
=== ======================== ===============================================
d) Aggregated information
Aggregated volume
Price
165.958
$41.81
=== ======================== ===============================================
e) Date of the transaction 2017-04-18
=== ======================== ===============================================
f) Place of the n/a
transaction
=== ======================== ===============================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Mr D S Redfern
=== ======================== ================================================
b) Position/status Chief Strategy Officer
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 13 April 2017 on
Ordinary Shares held in the Company's 2009
Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- --------------------------------
GBP16.47 67.977 (personal contribution)
--------- --------------------------------
GBP16.47 127.311 (personal contribution)
--------- --------------------------------
GBP16.47 92.391 (personal contribution)
--------- --------------------------------
GBP16.47 67.977 (personal contribution)
--------- --------------------------------
GBP16.47 127.311 (personal contribution)
--------- --------------------------------
GBP16.47 92.377 (personal contribution)
--------- --------------------------------
GBP16.47 67.977 (matching shares)
--------- --------------------------------
GBP16.47 127.311 (matching shares)
--------- --------------------------------
GBP16.47 92.391 (matching shares)
--------- --------------------------------
GBP16.47 67.977 (matching shares)
--------- --------------------------------
GBP16.47 127.311 (matching shares)
--------- --------------------------------
GBP16.47 92.377 (matching shares)
--------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
1,150.688
GBP16.47
=== ======================== ================================================
e) Date of the transaction 2017-04-18
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Ms C Thomas
=== ======================== ================================================
b) Position/status SVP, Human Resources
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 13 April 2017 on
Ordinary Shares held in the Company's 2009
Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- --------------------------------
GBP16.47 91.499 (personal contribution)
--------- --------------------------------
GBP16.47 186.252 (personal contribution)
--------- --------------------------------
GBP16.47 139.061(personal contribution)
--------- --------------------------------
GBP16.47 91.483 (personal contribution)
--------- --------------------------------
GBP16.47 186.252 (personal contribution)
--------- --------------------------------
GBP16.47 139.061 (personal contribution)
--------- --------------------------------
GBP16.47 91.499 (matching shares)
--------- --------------------------------
GBP16.47 186.252 (matching shares)
--------- --------------------------------
GBP16.47 139.061 (matching shares)
--------- --------------------------------
GBP16.47 91.483 (matching shares)
--------- --------------------------------
GBP16.47 186.252 (matching shares)
--------- --------------------------------
GBP16.47 139.061 (matching shares)
--------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
1,667.216
GBP16.47
=== ======================== ================================================
e) Date of the transaction 2017-04-18
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Mr P C Thomson
=== ======================== ================================================
b) Position/status President, Global Affairs
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 13 April 2017 on
Ordinary Shares held in the Company's 2009
Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- --------------------------------
GBP16.47 62.146 (personal contribution)
--------- --------------------------------
GBP16.47 113.955 (personal contribution)
--------- --------------------------------
GBP16.47 87.545 (personal contribution)
--------- --------------------------------
GBP16.47 62.146 (matching shares)
--------- --------------------------------
GBP16.47 113.955 (matching shares)
--------- --------------------------------
GBP16.47 87.545 matching shares)
--------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
527.292
GBP16.47
=== ======================== ================================================
e) Date of the transaction 2017-04-18
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =========================================================================
a) Name Mr D E Troy
=== ======================== ===============================================
b) Position/status SVP & General Counsel
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ===============================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 13 April 2017 on ADSs held
in the Company's 2009 Deferred Annual Bonus
Plan.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- --------------------------------
$41.81 47.220 (personal contribution)
--------- --------------------------------
$41.81 106.319 (personal contribution)
--------- --------------------------------
$41.81 88.057 (personal contribution)
--------- --------------------------------
$41.81 47.220 (personal contribution)
--------- --------------------------------
$41.81 106.319 (personal contribution)
--------- --------------------------------
$41.81 88.044 (personal contribution)
--------- --------------------------------
$41.81 47.220 (matching shares)
--------- --------------------------------
$41.81 106.319 (matching shares)
--------- --------------------------------
$41.81 88.057 (matching shares)
--------- --------------------------------
$41.81 47.220 (matching shares)
--------- --------------------------------
$41.81 106.319 (matching shares)
--------- --------------------------------
$41.81 88.044 (matching shares)
--------- --------------------------------
=== ======================== ===============================================
d) Aggregated information
Aggregated volume
Price
966.358
$41.81
=== ======================== ===============================================
e) Date of the transaction 2017-04-18
=== ======================== ===============================================
f) Place of the n/a
transaction
=== ======================== ===============================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ==========================================================================
a) Name Dr P J T Vallance
=== ======================== ================================================
b) Position/status President, R&D
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 13 April 2017 on
Ordinary Shares held in the Company's 2009
Deferred Annual Bonus Plan.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- --------------------------------
GBP16.47 134.685 (personal contribution)
--------- --------------------------------
GBP16.47 219.092 (personal contribution)
--------- --------------------------------
GBP16.47 151.043 (personal contribution)
--------- --------------------------------
GBP16.47 134.685 (personal contribution)
--------- --------------------------------
GBP16.47 219.092 (personal contribution)
--------- --------------------------------
GBP16.47 151.043 (personal contribution)
--------- --------------------------------
GBP16.47 134.685 (matching shares)
--------- --------------------------------
GBP16.47 219.092 (matching shares)
--------- --------------------------------
GBP16.47 151.043 (matching shares)
--------- --------------------------------
GBP16.47 134.685 (matching shares)
--------- --------------------------------
GBP16.47 219.092 (matching shares)
--------- --------------------------------
GBP16.47 151.043 (matching shares)
--------- --------------------------------
=== ======================== ================================================
d) Aggregated information
Aggregated volume
Price
2,019.280
GBP16.47
=== ======================== ================================================
e) Date of the transaction 2017-04-18
=== ======================== ================================================
f) Place of the n/a
transaction
=== ======================== ================================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEKLFFDZFBBBF
(END) Dow Jones Newswires
April 19, 2017 11:04 ET (15:04 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024
